Frederick Jiang, CFA

Frederick Jiang, CFA has a wealth of experience in the finance industry. Frederick began their career in 1994 as an Equity Research Analyst at ABN Amro HG Securities. In 1999, they became a Portfolio Manager at Waddell & Reed. In 2016, they became a Managing Partner at Coalescence Partners. In 2018, they co-founded Elixell Therapeutics, Inc. and served as a Board Director. In 2019, they became a Managing Partner at Falcon Creek Capital Advisor and an Investor and Board Director at HebeCell Corp. In 2020, they became a Co-Founder and Board Director at AccuraDX, an Investor and Board Director at Sedec Therapeutics, and a Managing Partner at Plaisance Capital Management LLC.

Frederick Jiang, CFA obtained a Bachelor's Degree from Central University of Finance and Economics in 1993. Frederick went on to receive a Master of Business Administration (M.B.A.) in Finance, General from New York University in 1999. Frederick also holds the CFA certification.